1. Home
  2. APOG vs BWAY Comparison

APOG vs BWAY Comparison

Compare APOG & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APOG

Apogee Enterprises Inc.

HOLD

Current Price

$37.64

Market Cap

766.1M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$14.07

Market Cap

674.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APOG
BWAY
Founded
1949
2003
Country
United States
Israel
Employees
N/A
129
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
766.1M
674.2M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
APOG
BWAY
Price
$37.64
$14.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$47.00
$13.25
AVG Volume (30 Days)
149.7K
149.3K
Earning Date
04-24-2026
05-13-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
N/A
EPS
2.52
N/A
Revenue
$1,404,733,000.00
N/A
Revenue This Year
N/A
$309.69
Revenue Next Year
$2.07
$26.21
P/E Ratio
$15.31
$81.98
Revenue Growth
3.21
N/A
52 Week Low
$30.75
$10.21
52 Week High
$46.14
$26.63

Technical Indicators

Market Signals
Indicator
APOG
BWAY
Relative Strength Index (RSI) 56.29 35.47
Support Level $36.94 $11.90
Resistance Level $37.97 $16.51
Average True Range (ATR) 1.17 0.55
MACD 0.30 -0.16
Stochastic Oscillator 71.53 9.03

Price Performance

Historical Comparison
APOG
BWAY

About APOG Apogee Enterprises Inc.

Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company geographically operates in the United States, Canada, and Brazil, with the majority revenue generated from the United States.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: